P35822
Gene name |
Ptprk (Ptpk) |
Protein name |
Receptor-type tyrosine-protein phosphatase kappa |
Names |
Protein-tyrosine phosphatase kappa, R-PTP-kappa |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:19272 |
EC number |
3.1.3.48: Phosphoric monoester hydrolases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P35822
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P35822-F1 | Predicted | AlphaFoldDB |
35 variants for P35822
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs46969210 | 27 | L>H | No | EVA | |
| rs3400789685 | 41 | P>L | No | EVA | |
| rs3389097705 | 58 | H>Y | No | EVA | |
| rs13463066 | 64 | P>S | No | EVA | |
| rs3389086420 | 176 | S>N | No | EVA | |
| rs3389067584 | 392 | P>S | No | EVA | |
| rs3389097668 | 405 | I>S | No | EVA | |
| rs3389093304 | 477 | S>G | No | EVA | |
| rs3389093058 | 489 | P>S | No | EVA | |
| rs3389072104 | 532 | S>P | No | EVA | |
| rs3389097641 | 536 | A>V | No | EVA | |
| rs37184126 | 538 | P>S | No | EVA | |
| rs3389103814 | 556 | V>E | No | EVA | |
| rs3389037174 | 592 | A>V | No | EVA | |
| rs3389072089 | 610 | T>S | No | EVA | |
| rs3389095582 | 673 | L>F | No | EVA | |
| rs3389095594 | 733 | A>S | No | EVA | |
| rs3389090133 | 734 | T>I | No | EVA | |
| rs3389093229 | 757 | S>G | No | EVA | |
| rs3389097658 | 764 | I>F | No | EVA | |
| rs3406006137 | 796 | H>Y | No | EVA | |
| rs3389095733 | 858 | V>I | No | EVA | |
| rs3389095508 | 880 | R>G | No | EVA | |
| rs3389086435 | 887 | H>R | No | EVA | |
| rs3389086474 | 896 | S>I | No | EVA | |
| rs3401002343 | 911 | S>* | No | EVA | |
| rs3400994797 | 915 | D>E | No | EVA | |
| rs3401093049 | 927 | R>L | No | EVA | |
| rs3389067627 | 1125 | V>G | No | EVA | |
| rs3389037154 | 1204 | R>Q | No | EVA | |
| rs3389093308 | 1225 | M>I | No | EVA | |
| rs3389095526 | 1275 | D>V | No | EVA | |
| rs3389060687 | 1288 | I>N | No | EVA | |
| rs3389072137 | 1292 | N>S | No | EVA | |
| rs3389080498 | 1375 | Q>* | No | EVA |
No associated diseases with P35822
15 regional properties for P35822
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Tyrosine-specific protein phosphatase, PTPase domain | 898 - 1161 | IPR000242-1 |
| domain | Tyrosine-specific protein phosphatase, PTPase domain | 1190 - 1455 | IPR000242-2 |
| domain | Tyrosine-specific protein phosphatases domain | 1079 - 1150 | IPR000387-1 |
| domain | Tyrosine-specific protein phosphatases domain | 1367 - 1444 | IPR000387-2 |
| domain | MAM domain | 30 - 193 | IPR000998 |
| domain | Protein-tyrosine phosphatase, catalytic | 1057 - 1158 | IPR003595-1 |
| domain | Protein-tyrosine phosphatase, catalytic | 1347 - 1452 | IPR003595-2 |
| domain | Immunoglobulin subtype | 200 - 288 | IPR003599 |
| domain | Fibronectin type III | 290 - 388 | IPR003961-1 |
| domain | Fibronectin type III | 389 - 475 | IPR003961-2 |
| domain | Fibronectin type III | 487 - 594 | IPR003961-3 |
| domain | Immunoglobulin-like domain | 195 - 280 | IPR007110 |
| domain | Immunoglobulin I-set | 200 - 277 | IPR013098 |
| active_site | Protein-tyrosine phosphatase, active site | 1098 - 1108 | IPR016130-1 |
| active_site | Protein-tyrosine phosphatase, active site | 1392 - 1402 | IPR016130-2 |
Functions
| Description | ||
|---|---|---|
| EC Number | 3.1.3.48 | Phosphoric monoester hydrolases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
11 GO annotations of cellular component
| Name | Definition |
|---|---|
| axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| cell junction | A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella. |
| cell surface | The external part of the cell wall and/or plasma membrane. |
| cell-cell junction | A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| intracellular membrane-bounded organelle | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
| leading edge membrane | The portion of the plasma membrane surrounding the leading edge of a motile cell. |
| neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| photoreceptor outer segment | The outer segment of a vertebrate photoreceptor that contains a stack of membrane discs embedded with photoreceptor proteins. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| beta-catenin binding | Binding to a catenin beta subunit. |
| gamma-catenin binding | Binding to catenin complex gamma subunit. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| protein tyrosine phosphatase activity | Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
15 GO annotations of biological process
| Name | Definition |
|---|---|
| cell adhesion | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
| cell migration | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| cellular response to reactive oxygen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
| cellular response to UV | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
| focal adhesion assembly | The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity. |
| negative regulation of cell cycle | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| negative regulation of cell migration | Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. |
| negative regulation of cell population proliferation | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| negative regulation of DNA-templated transcription | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| negative regulation of keratinocyte proliferation | Any process that decreases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population. |
| neuron projection development | The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| protein dephosphorylation | The process of removing one or more phosphoric residues from a protein. |
| protein localization to cell surface | A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane. |
| signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| transforming growth factor beta receptor signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to a transforming growth factor beta receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
8 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Homo sapiens (Human) | PR |
| P10586 | PTPRF | Receptor-type tyrosine-protein phosphatase F | Homo sapiens (Human) | PR |
| P23468 | PTPRD | Receptor-type tyrosine-protein phosphatase delta | Homo sapiens (Human) | PR |
| P08575 | PTPRC | Receptor-type tyrosine-protein phosphatase C | Homo sapiens (Human) | PR |
| P28827 | PTPRM | Receptor-type tyrosine-protein phosphatase mu | Homo sapiens (Human) | PR |
| Q15262 | PTPRK | Receptor-type tyrosine-protein phosphatase kappa | Homo sapiens (Human) | PR |
| P49446 | Ptpre | Receptor-type tyrosine-protein phosphatase epsilon | Mus musculus (Mouse) | PR |
| Q64487 | Ptprd | Receptor-type tyrosine-protein phosphatase delta | Mus musculus (Mouse) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MDVAAAALPA | FVALWLLYPW | PLLGSALGQF | SAGGCTFDDG | PGACDYHQDL | YDDFEWVHVS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AQEPHYLPPE | MPQGSYMVVD | SSNHDPGEKA | RLQLPTMKEN | DTHCIDFSYL | LYSQKGLNPG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| TLNILVRVNK | GPLANPIWNV | TGFTGRDWLR | AELAVSTFWP | NEYQVIFEAE | VSGGRSGYIA |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IDDIQVLSYP | CDKSPHFLRL | GDVEVNAGQN | ATFQCIATGR | DAVHNKLWLQ | RRNGEDIPVA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| QTKNINHRRF | AASFRLQEVT | KTDQDLYRCV | TQSERGSGVS | NFAQLIVREP | PRPIAPPQLL |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GVGPTYLLIQ | LNANSIIGDG | PIILKEVEYR | MTSGSWTETH | AVNAPTYKLW | HLDPDTEYEI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| RVLLTRPGEG | GTGLPGPPLI | TRTKCAEPMR | TPKTLKIAEI | QARRIAVDWE | SLGYNITRCH |
| 430 | 440 | 450 | 460 | 470 | 480 |
| TFNVTICYHY | FRGHNESRAD | CLDMDPKAPQ | HVVNHLPPYT | NVSLKMILTN | PEGRKESEET |
| 490 | 500 | 510 | 520 | 530 | 540 |
| IIQTDEDVPG | PVPVKSLQGT | SFENKIFLNW | KEPLEPNGII | TQYEVSYSSI | RSFDPAVPVA |
| 550 | 560 | 570 | 580 | 590 | 600 |
| GPPQTVSNLW | NSTHHVFMHL | HPGTTYQFFI | RASTVKGFGP | ATAINVTTNI | SAPSLPDYEG |
| 610 | 620 | 630 | 640 | 650 | 660 |
| VDASLNETAT | TITVLLRPAQ | AKGAPISAYQ | IVVEQLHPHR | TKREAGAMEC | YQVPVTYQNA |
| 670 | 680 | 690 | 700 | 710 | 720 |
| LSGGAPYYFA | AELPPGNLPE | PAPFTVGDNR | TYKGFWNPPL | APRKGYNIYF | QAMSSVEKET |
| 730 | 740 | 750 | 760 | 770 | 780 |
| KTQCVRIATK | AAATEEPEVI | PDPAKQTDRV | VKIAGISAGI | LVFILLLLVV | IVIVKKSKLA |
| 790 | 800 | 810 | 820 | 830 | 840 |
| KKRKDAMGNT | RQEMTHMVNA | MDRSYADQST | LHAEDPLSLT | FMDQHNFSPR | LPNDPLVPTA |
| 850 | 860 | 870 | 880 | 890 | 900 |
| VLDENHSATA | ESSRLLDVPR | YLCEGTESPY | QTGQLHPAIR | VADLLQHINL | MKTSDSYGFK |
| 910 | 920 | 930 | 940 | 950 | 960 |
| EEYESFFEGQ | SASWDVAKKD | QNRAKNRYGN | IIAYDHSRVI | LQPVEDDPSS | DYINANYIDI |
| 970 | 980 | 990 | 1000 | 1010 | 1020 |
| WLYRDGYQRP | SHYIATQGPV | HETVYDFWRM | VWQEQSACIV | MVTNLVEVGR | VKCYKYWPDD |
| 1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
| TEVYGDFKVT | CVEMEPLAEY | VVRTFTLERR | GYNEIREVKQ | FHFTGWPDHG | VPYHATGLLS |
| 1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
| FIRRVKLSNP | PSAGPIVVHC | SAGAGRTGCY | IVIDIMLDMA | EREGVVDIYN | CVKALRSRRI |
| 1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
| NMVQTEEQYI | FIHDAILEAC | LCGETAIPVC | EFKAAYFDMI | RIDSQTNSSH | LKDEFQTLNS |
| 1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
| VTPRLQAEDC | SIACLPRNHD | KNRFMDMLPP | DRCLPFLITI | DGESSNYINA | ALMDSYRQPA |
| 1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
| AFIVTQYPLP | NTVKDFWRLV | YDYGCTSIVM | LNEVDLSQGC | PQYWPEEGML | RYGPIQVECM |
| 1330 | 1340 | 1350 | 1360 | 1370 | 1380 |
| SCSMDCDVIN | RIFRICNLTR | PQEGYLMVQQ | FQYLGWASHR | EVPGSKRSFL | KLILQVEKWQ |
| 1390 | 1400 | 1410 | 1420 | 1430 | 1440 |
| EECEEGEGRT | IIHCLNGGGR | SGMFCAIGIV | VEMVKRQNVV | DVFHAVKTLR | NSKPNMVEAP |
| 1450 | |||||
| EQYRFCYDVA | LEYLESS |